Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes
暂无分享,去创建一个
R. Haeusler | B. Staels | J. McGinty | B. Laferrère | P. Homel | C. W. Roux | J. Alaghband-Zadeh | J. Alaghband‐Zadeh | R. Vincent | M. Embrey | R. Dutia | S. O'Brien | K. Agenor | J. Yu | C. Roux
[1] M. Hayden,et al. Loss of Cyp8b1 Improves Glucose Homeostasis by Increasing GLP-1 , 2014, Diabetes.
[2] M. Bellon,et al. Rapid gastric and intestinal transit is a major determinant of changes in blood glucose, intestinal hormones, glucose absorption and postprandial symptoms after gastric bypass , 2014, Obesity.
[3] Deepak L. Bhatt,et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. , 2014, The New England journal of medicine.
[4] C. le Roux,et al. Urine Bile Acids Relate to Glucose Control in Patients with Type 2 Diabetes Mellitus and a Body Mass Index Below 30 kg/m2 , 2014, PloS one.
[5] V. Tremaroli,et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy , 2014, Nature.
[6] M. Patti,et al. Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin. , 2014, The Journal of clinical endocrinology and metabolism.
[7] C. Klaassen,et al. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice. , 2013, Toxicology and applied pharmacology.
[8] C. Beglinger,et al. Bile acids and gut peptide secretion after bariatric surgery: A 1‐year prospective randomized pilot trial , 2013, Obesity.
[9] D. Accili,et al. Human Insulin Resistance Is Associated With Increased Plasma Levels of 12α-Hydroxylated Bile Acids , 2013, Diabetes.
[10] C. L. le Roux,et al. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery , 2013, Scandinavian journal of gastroenterology.
[11] Jimmy D Bell,et al. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding , 2013, Gut.
[12] R. Sherwood,et al. Higher circulating bile acid concentrations in obese patients with type 2 diabetes , 2013, Annals of clinical biochemistry.
[13] J. Tap,et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. , 2013, The American journal of clinical nutrition.
[14] W. Strodel,et al. A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass , 2013, Diabetes Care.
[15] P. Mattei,et al. Systemic bile acid sensing by G protein‐coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP‐1 release , 2013, British journal of pharmacology.
[16] M. Horowitz,et al. Effects of rectal administration of taurocholic acid on glucagon‐like peptide‐1 and peptide YY secretion in healthy humans , 2013, Diabetes, obesity & metabolism.
[17] L. Kaplan,et al. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity , 2013, International Journal of Obesity.
[18] S. Madsbad,et al. Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux‐en‐Y gastric bypass , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[19] Lee M. Kaplan,et al. Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity , 2013, Science Translational Medicine.
[20] C. Cobelli,et al. The Effect of a Bile Acid Sequestrant on Glucose Metabolism in Subjects With Type 2 Diabetes , 2013, Diabetes.
[21] S. Klein,et al. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. , 2013, The Journal of clinical endocrinology and metabolism.
[22] S. Woods,et al. Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. , 2013, Endocrinology.
[23] Barbara Gross,et al. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease , 2012, Journal of Lipid Research.
[24] N. Nagelkerke,et al. Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers , 2012, Diabetologia.
[25] J. H. Bekker,et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. , 2012, Endocrinology.
[26] M. Laakso,et al. Conjugated Bile Acids Associate with Altered Rates of Glucose and Lipid Oxidation after Roux-en-Y Gastric Bypass , 2012, Obesity Surgery.
[27] Yaniv Harel,et al. Accelerated Gastric Emptying but No Carbohydrate Malabsorption 1 Year After Gastric Bypass Surgery (GBP) , 2012, Obesity Surgery.
[28] D. Accili,et al. Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. , 2012, Cell metabolism.
[29] S. Haneuse,et al. A Multisite Study of Long-term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass , 2012, Obesity Surgery.
[30] B. Angelin,et al. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19 , 2011, Journal of internal medicine.
[31] A. von Eckardstein,et al. Bile Acid Metabolites in Serum: Intraindividual Variation and Associations with Coronary Heart Disease, Metabolic Syndrome and Diabetes Mellitus , 2011, PloS one.
[32] M. Krempf,et al. Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults , 2011, Nutrition & metabolism.
[33] R. Straka,et al. Profile of serum bile acids in non-cholestatic volunteers: gender-related differences in response to fenofibrate , 2011, Clinical pharmacology and therapeutics.
[34] J. Stoker,et al. Alterations of Hormonally Active Fibroblast Growth Factors after Roux-en-Y Gastric Bypass Surgery , 2011, Digestive Diseases.
[35] B. Staels,et al. Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes , 2011, Current diabetes reports.
[36] R. Sherwood,et al. The relationship between postprandial bile acid concentration, GLP‐1, PYY and ghrelin , 2011, Clinical endocrinology.
[37] F. Kuipers,et al. Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism , 2010, Hepatology.
[38] J. Tap,et al. Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss , 2010, Diabetes.
[39] D. Pournaras,et al. Postprandial plasma bile acid responses in normal weight and obese subjects , 2010, Annals of clinical biochemistry.
[40] R. Goodlad,et al. Gut Hypertrophy After Gastric Bypass Is Associated With Increased Glucagon-Like Peptide 2 and Intestinal Crypt Cell Proliferation , 2010, Annals of surgery.
[41] J. Chiang,et al. Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.
[42] J. Auwerx,et al. TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.
[43] J. Holst,et al. Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism , 2009, Obesity.
[44] M. Crowell,et al. Human gut microbiota in obesity and after gastric bypass , 2009, Proceedings of the National Academy of Sciences.
[45] S. Strom,et al. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α‐hydroxylase gene expression , 2009, Hepatology.
[46] A. M. Habib,et al. Glucose Sensing in L Cells: A Primary Cell Study , 2008, Cell metabolism.
[47] J. Auwerx,et al. Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. , 2007, Biochemical and biophysical research communications.
[48] T. Lundåsen,et al. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man , 2006, Journal of internal medicine.
[49] Josep Vidal,et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. , 2006, The Journal of clinical endocrinology and metabolism.
[50] Folkert Kuipers,et al. The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice* , 2006, Journal of Biological Chemistry.
[51] Ke Ma,et al. Farnesoid X receptor is essential for normal glucose homeostasis. , 2006, The Journal of clinical investigation.
[52] Dae-Joong Kang,et al. Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005. , 2006, Journal of Lipid Research.
[53] J. Auwerx,et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.
[54] Timothy M Willson,et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[55] G. Tsujimoto,et al. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. , 2005, Biochemical and biophysical research communications.
[56] D. Pertsemlidis,et al. Composition of biliary lipids and kinetics of bile acids after cholecystectomy in man , 1976, The American Journal of Digestive Diseases.
[57] R. Soriano,et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. , 2004, Endocrinology.
[58] B. Casetta,et al. Quantitative Analysis of Bile Acids in Human Plasma by Liquid Chromatography-Electrospray Tandem Mass Spectrometry: A Simple and Rapid One-Step Method , 2003, Clinical chemistry and laboratory medicine.
[59] D. French,et al. Printed in U.S.A. Copyright © 2002 by The Endocrine Society Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity , 2022 .
[60] Masahiro Tohkin,et al. Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.
[61] G. Kullak-Ublick,et al. Long‐term effects of cholecystectomy on bile acid metabolism , 1995, Hepatology.
[62] L. Magee,et al. R 2 Measures Based on Wald and Likelihood Ratio Joint Significance Tests , 1990 .
[63] F. Berr,et al. Effects of cholecystectomy on the kinetics of primary and secondary bile acids. , 1989, The Journal of clinical investigation.
[64] T. Akiyoshi,et al. Altered Bile Acid Metabolism in Nonobese, Spontaneously Diabetic (NOD) Mice , 1985, Diabetes.
[65] K. Einarsson,et al. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. , 1982, The Journal of clinical investigation.
[66] D. H. Gregory,et al. Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy. , 1973, New England Journal of Medicine.